In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Multimodality amyloidosis imaging

EACVI webinar

09/06/2020 18:00 09/06/2020 19:00 Europe/Paris Multimodality amyloidosis imaging

Access event page

European Association of Cardiovascular Imaging DD/MM/YYYY
European Association of Cardiovascular Imaging
Nuclear Imaging
Cardiac Magnetic Resonance

Focus on

Learning objectives

After watching the webinar, participants will be able to:

  • Understand how to diagnose cardiac amyloidosis;
  • Understand respective advantages and disadvantages of CMR and nuclear imaging; and
  • Understand therapeutic implications of diagnosis of amyloidosis.



Cardiac amyloidosis is a public health problem with a poor outcome. There are currently medications available to treat this disease. Therefore, early detection of this condition is crucial.


  Questions from the audience answered by Assoc. Prof. Marianna Fontana.